Federal Register - December 8, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
69660
Federal Register / Vol. 86, No. 233 / Wednesday, December 8, 2021 / Notices
Dated: December 2, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202126523 Filed 12721; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Cancer Institute; Notice of Closed Meetings
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel;
Outstanding Investigator Award.
Date: January 2021, 2022.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W530, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Shamala K. Srinivas, Ph.D., Associate Director, Office of Referral, Review, and Program Coordination, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W530, Rockville, Maryland 20850, 2402766442, ss537t@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Division of Cancer Epidemiology and Genetics DCEG
Field and Biospecimen Support Services.
Date: January 20, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850, 2402765460, jfang@mail.nih.gov.
VerDate Sep<11>2014
16:53 Dec 07, 2021
Jkt 256001
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Trials Support Unit TEP 1A.
Date: January 27, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 2402765856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Trials Support Unit TEP 1B.
Date: January 28, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 2402765856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP1A:
SBIR Contract Review.
Date: February 1, 2022.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W412, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator, Division of Extramural Activities, Program and Review Extramural Staff Training Office, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412, Rockville, Maryland 20850, 2402766444, dingi@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP1B:
SBIR Contract Review.
Date: February 2, 2022.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W412, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator, Division of Extramural Activities, Program and Review Extramural Staff Training Office, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412, Rockville, Maryland 20850, 2402766444, dingi@mail.nih.gov.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP3: NCI
Clinical and Translational Cancer Research.
Date: February 34, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W236, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Rockville, Maryland 20850, 2402765256, shuli.xia@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP2: NCI
Clinical and Translational Cancer Research.
Date: February 34, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 2402767286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Early Detection Research Network U01, U24, U2C
Grant Review.
Date: February 78, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W552, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Jeanette Irene Marketon, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W552, National Cancer Institute, NIH, Rockville, Maryland 20850, 2402766780, jeanette.marketon@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP3A:
Cancer Treatment Technologies for LowResource Settings.
Date: February 1516, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850, 2402765460, jfang@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Predoc
E:FRFM08DEN1.SGM
08DEN1
